Pruritus associated with onabotulinumtoxina treatment of neuromuscular pain

Derek Ho, Jared Jagdeo

Research output: Contribution to journalArticle

1 Scopus citations

Abstract

OnabotulinumtoxinA is one of the most widely used agents for cosmetic and medical treatment. Studies have shown that onabotulinumtoxinA is safe and effective with minimal adverse events, and is often well tolerated by patients. We present a patient who developed neuropathic pruritus five days after treatment with onabotulinumtoxinA for neuromuscular pain. This case highlights the treatment of pruritus associated with onabotulinumtoxinA and the therapeutic method to resolve the patient's pruritus.

Original languageEnglish (US)
Pages (from-to)199-200
Number of pages2
JournalJournal of Drugs in Dermatology
Volume14
Issue number2
StatePublished - Feb 1 2015

ASJC Scopus subject areas

  • Dermatology

Fingerprint Dive into the research topics of 'Pruritus associated with onabotulinumtoxina treatment of neuromuscular pain'. Together they form a unique fingerprint.

  • Cite this